Cell proliferation and survival require continuous ribosome biogenesis and protein synthesis. Genes encoding ribosomal RNA (rRNA) are physically located in a specialized substructure within the nucleus known as the nucleolus, which has a central role in the biogenesis of ribosomes. Matrix metalloproteinase-2 (MMP-2) was previously detected in the nucleus. However, its role there is elusive. Herein we report that MMP-2 resides within the nucleolus to regulate rRNA transcription. MMP-2 is enriched at the promoter region of rRNA gene repeats and its inhibition downregulates pre-rRNA transcription. The Nterminal tail of histone H3 is clipped by MMP-2 in the nucleolus and is associated with increased rRNA transcription. Knocking down/out MMP-2 or inhibiting its activity prevents histone H3 cleavage and reduces both rRNA transcription and cell proliferation. In addition to the known extracellular roles of MMP-2 in tumor growth, our data reveal an epigenetic mechanism whereby intranucleolar MMP-2 regulates cell proliferation through histone proteolysis and facilitation of rRNA transcription.
Introduction
Cell proliferation is a complex and tightly controlled process [1] involving not only DNA replication but also biosynthesis of a large number of proteins. The nucleolus is the most prominent structure in the nucleus where transcription of ribosomal genes encoding ribosomal RNA (rRNA) occurs [2] . However, the function of the nucleolus goes beyond ribosome production as it is also involved in post-transcriptional modification of RNA, cell cycle regulation, stress responses and cell senescence [3] .
Multiple cell signals are coordinated through epigenetic regulation, including DNA methylation and post-translational modifications of the N-terminal tails of core histones constituting the nucleosome [4] . The most studied histone post-translational modifications include acetylation, ubiquitylation and methylation of lysines, arginine methylation and serine and threonine phosphorylation [5] . Histone modifications occur on multiple but specific residues. These combinatorial modifications of histones can also act as binding platforms for specific proteins that read particular histone marks, leading to active or silenced genomic regions.
While the roles of many N-terminal tail histone post-translational modifications in gene expression are well established [4] , the significance and mechanisms of histone tail proteolysis are less clear. Chromatin modification through the proteolytic cleavage of histones is a rapidly developing topic in epigenetics [6] . Cathepsin L was the first identified protease involved in epigenetic regulation by histone proteolysis in mouse cells [7] .
However, the identity of functionally related yeast and human protease(s) has not been fully elucidated [8, 9] . Functionally, histone N-termini are not required for the assembly of the nucleosome per se but are critical in the formation of more compact chromatin structures beyond the 10 nm linear nucleosome structure [10] . Thus, the consequence of histone N-terminal proteolytic removal may be to promote an activated chromatin state that is resistant to chromatin compaction [11] [12] [13] [14] [15] .
Matrix metalloproteinase-2 (MMP-2) was first identified as a ubiquitously expressed protease which targets extracellular matrix proteins (also named gelatinase A), but is now recognized through its proteolytic activities to be involved in various intracellular processes, both physiological and pathological [16] . MMP-2 is localized in specific cellular compartments and organelles including the nucleus [17] , the sarcomere [18] , caveolae [19] , mitochondria and the mitochondria-associated membrane [20] . The intracellular roles of MMPs are still incompletely understood. The signal sequence of 72 kDa MMP-2 inefficiently targets it to the secretory pathway and approximately half of nascent MMP-2 remains intracellular [21] . Several intracellular targets of MMP-2 have been discovered including titin [22] , troponin I [18] , α-actinin [23] and glycogen synthase kinase-3β [24] . Activation of intracellular MMP-2 has been linked to pathological conditions such as oxidative stress injuries to the heart [22] and brain [25] as well as tumor growth [26] . MMP-9, a related MMP also found in the nucleus [17] was recently found to epigenetically regulate mouse osteoclast differentiation through cleavage of histone H3 [27] .
MMP-2 was the first MMP to be found inside the nucleus [17] , yet its biological functions in that organelle remain elusive. We report here that nuclear MMP-2 is enriched at the sites of transcription within the nucleolus. We provide evidence that intracellular MMP-2 co-localizes with nucleolus specific markers and is found in purified nucleolar fractions. Further, we show that MMP-2 is bound to chromatin within the promoter of the ribosomal RNA (rRNA) gene, and that it is directly involved in rRNA gene transcription.
We provide data showing that MMP-2 is able to clip the N-terminal tail of histone H3 within the nucleolus, which would reduce the capacity of the chromatin to compact.
Finally, we show that silencing or knocking-out MMP-2 inhibits pre-rRNA transcription as well as cell proliferation. The involvement of MMP-2 in ribosomal gene expression sheds light on a novel role this protease may play in oncogenesis.
Results

MMP-2 co-localizes with nucleolar markers
MMP-2 has been located in the nucleus of cardiomyocytes [17, 28] , endothelial cells [29] and neurons [25] . Closer inspection of our previous immunogold electron microscopy and immunofluorescence data [17, 28] suggested to us that MMP-2 might be present within the nucleolus. Consequently, we wanted to more carefully examine the localization of nuclear MMP-2 in order to gain insight into potential MMP-2 nuclear functions.
Immunofluorescence of MMP-2 revealed staining throughout the cell ( Figure 1A ).
In addition to the expected cytoplasmic staining, there was a clear abundance of signal in the nucleus. Within the nucleus, there were abundant small nuclear foci of MMP-2 staining scattered throughout the nucleoplasm but several foci stood out as brighter and slightly larger (encircled in Fig. 1A ). This pattern of MMP-2 staining is distinct from most RNA polymerase II transcription factors whose nucleoplasmic staining reveals an exclusion zone corresponding to the nucleolus [30] . Since MMP-2 staining was found in chromatindepleted regions of the nucleus, we tested for colocalization with a nucleolar marker, fibrillarin, which localizes to the fibrillar center of the nucleolus. We found that the bright MMP-2 foci co-localized with fibrillarin (Fig. 1A) . We confirmed the co-localization of MMP-2 with fibrillarin in several other human cancer cell lines including MCF7, PC-3, and U-373 MG cells ( Supplementary Fig. S1 ).
To validate the presence of MMP-2 within the nucleolus, we isolated highly purified nucleoli from U2-OS cells. We confirmed their purity by the absence of α-tubulin (cytoplasmic marker), FUS/TLS (nuclear marker), and by the presence of fibrillarin in Western blots (Fig. 1B) . A Western blot for MMP-2 in the nucleoli preparation showed a band of approximately 72 kDa, in accordance with recombinant human MMP-2 and conditioned media from human HT-1080 cells (commonly used as an MMP-2 standard) (Fig. 1C) . MMP-2 was detected in immunoprecipitates from purified nucleoli as a prominent 72 kDa band, which was absent in IgG control immunoprecipitate (Fig. 1D ).
These data strongly suggest the presence of MMP-2 within the nucleoli of human cancer cell lines. Given the apparent localization of MMP-2 within the nucleolus to sites of active transcription, we next sought to determine whether MMP-2 associates with nucleolar chromatin. Consequently, we performed nucleolar chromatin immunoprecipitation (ChIP) assays as previously described [31] , followed by qPCR using primer sets mapping different loci (h0, h4, h8, h18, h37.9 or h42.1) across the rDNA gene (Fig. 2C) . Antibodies against both CCCTC-binding factor (CTCF) and upstream binding transcription factor (UBF), known factors involved in rDNA gene transcription, were used as positive controls. As previously reported, CTCF was enriched mainly to the spacer promoter regions h37.9 and h42.1 [32] , whereas UBF showed enrichment across the rDNA gene [33] . Interestingly, we found that MMP-2 binds to different regions of the rDNA gene and is mainly enriched at h0 locus of the rDNA gene promoter (Fig. 2C) . This is consistent with a role for MMP-2 in regulating rRNA transcription initiation.
MMP
MMP-2 clips histones at their N-termini
Given that the related protease, MMP-9 was shown to positively regulate RNA pol II transcription through proteolytic removal of histone H3 N-terminus [27] we tested whether MMP-2 can proteolyze nucleosomal histones; (H2A, H2B, H4 and H3 isoforms).
Incubation with MMP-2 resulted in concentration-dependent proteolysis of all tested recombinant histones with histone H3 isoforms showing the highest susceptibility (Fig. 3) .
Inhibition of MMP-2 activity with the MMP-2 preferring inhibitor ARP-100 (10 µM) prevented histone proteolysis.
We then focused on MMP-2 induced proteolysis of histone H3 due to its wellknown role in epigenetic regulation of gene expression [34] . After carrying out in vitro proteolysis by MMP-2 with different histone H3 isoforms, we did Western blotting using specific antibodies against histone H3 N-terminal or C-terminal domains (Fig. 4A) . We observed histone H3 degradation products only when using C-terminal antibodies, indicating that MMP-2 mediated proteolysis occurs at their N-termini.
We next performed N-terminal sequencing of recombinant histone H3.3 that had been incubated at 37°C for 1 h with MMP-2. Recombinant histone was used to avoid interference in protein sequencing due to posttranslational modifications. Although we observed at least three degradation bands of histone H3.3 by immunoblot (Fig. 4B) , the most prominent proteolytic product migrating at ~17 kDa was also seen with shorter incubation times down to 15 min (data not shown). This 17 kDa band was isolated and sequenced and the results showed that the initial cleavage site is located between the K18 and Q19 residues, G13KAPRK18-Q19LATKA ( Fig. 4B and see the Supplement for mass spectrometry data). Using in silico analysis with CleavPredict [35] , we also identified other potential MMP-2 cleavage sites at amino acid positions R41, T46, A48, E51, E74, D92 and R130.
We next determined whether exogenous MMP-2 cleaves native histone H3 isolated from nucleoli near its N-terminus. We used histone H3 antibodies specific against posttranslational modifications of the amino acids nearest to the predicted K18-Q19 MMP-2 cleavage site. Purified nucleoli were isolated from U2-OS cells, and then nucleolar histones were isolated and incubated with MMP-2 for 4 h at 37°C. Figure 4C shows that there was no detectable histone H3 cleavage product using anti-H3 K18 ac , in contrast to the approximately 17 kDa band revealing a histone H3 degradation product detected using Cterminal anti-H3 (Fig. 4B ). This histone H3 cleavage product was also detected using anti-H3 K23ac, anti-H3 K27m 3 or anti-H3 K36m 3 (data not shown). Our results show that an important MMP-2 cleavage site on both recombinant and nucleolar histone H3 is located at its N-terminus between the K18 and Q19 residues.
Nucleolar MMP-2 cleaves histone H3 in nucleoli
To explore whether endogenous MMP-2 is able to cleave histone H3 in situ within the nucleolus, we first tested for a potential interaction between them. MMP-2 was immunoprecipitated from purified nucleoli from U2-OS cells using anti-MMP-2 (ab92536).
Western blots showed that histone H3 co-immunoprecipitates with MMP-2 within nucleoli (Fig. 5A ). To evaluate whether MMP-2 within the intact nucleolus has proteolytic activity, we carried out degradation assays using isolated purified nucleoli. Nucleolar preparations were incubated for 4 h at 4ºC or 37ºC, electrophoresed, and immunoblotted with antihistone H3 C-terminal antibody. Our results showed histone H3 is clipped in the purified nucleolar fractions incubated at 37ºC but not 4ºC. Importantly the MMP-2 inhibitor ARP-100 prevented histone H3 clipping (Fig. 5B) . This suggested the presence of MMP-2 proteolytic activity in purified nucleolar preparations.
In order to test that the N-terminus of histone H3 in situ is the site of cleavage by endogenous MMP-2, U2-OS cells were treated either with a cell-permeable MMP inhibitor that preferentially inhibits MMP-2, ONO-4817 (10 μM), or with a peroxynitrite donor, SIN-1 (100 μM), to activate endogenous MMP-2 by oxidative stress [36] . Neither compound was cytotoxic at the selected concentrations ( Supplementary Fig. S2 ). The cells were treated for 3 days, given that the half-life of histone H3.3 turnover is about 3.5 days [37] . As shown in Figure 5C , nucleolar MMP-2 was able to cleave the N-terminus of histone H3 in nucleoli to a 17 kDa fragment detected using a histone H3 C-terminal antibody. This cleavage was decreased by ONO-4817 and increased with SIN-1 treatment.
As MMP-2 cleavage of histone H3 occurred at a well-recognized acetylation site (K18) [5] , we tested whether acetylation of histone H3 affects its cleavage by MMP-2. To this end, U2-OS cells were first treated with ONO-4817 for 3 days, and then treated for an additional 24 h with C646, a histone acetyltransferase inhibitor, or with trichostatin-A, a histone deacetylase inhibitor. C646 enhances the proportion of deacetylated histones in U2-OS cells, whereas trichostatin-A enhances histone acetylation. After these treatments, the purified nucleoli were isolated and an immunoblot against histone H3 C-terminus was performed on the nucleolar extract. We observed enhanced histone H3 cleavage to a product migrating at 17 kDa in trichostatin-A-treated cells and attenuated histone H3 cleavage in C646-treated cells (Fig. 5D ). Taken together, our results confirm that MMP-2 from nucleoli is proteolytically active and cleaves the N-terminus of histone H3 in an acetylation dependent manner.
MMP-2 mediates rRNA transcription and cancer cell proliferation
To test whether there is a functional role of MMP-2 at transcription sites in the nucleolus, we silenced MMP-2 in U2-OS cells using two specific siRNAs against MMP-2, which effectively diminished its protein level and activity (Fig. 6A ) as well as its mRNA level (Fig. 6B) . Importantly, the siRNAs did not affect MMP-9 activity (Fig. 6A ). MMP-2 knockdown reduced the synthesis of pre-rRNA by approximately 36% (siMMP-2 A ) and 30% (siMMP-2 B ) compared to siRNA control (Fig. 6C) . Likewise, synthesis of pre-rRNA was significantly diminished to a similar extent when cells were treated with either of the two MMP-2 inhibitors (ARP-100 or ONO-4817). As expected, the RNA polymerase inhibitor actinomycin D, used as a positive control, abolished pre-rRNA expression (Fig.   6D ).
We then measured U2-OS cell proliferation over 3 days in both silenced and control cells. Figure 6E shows that silencing MMP-2 using siRNAs results in a slower cell proliferation rate than cells transfected with control siRNA. We also addressed the biological role of MMP-2 using cells treated with MMP inhibitors (MMP-2 preferring:
ONO-4817; pan-MMP: GM6001) at non-cytotoxic concentrations ( Supplementary Fig.   S2 ). Cell proliferation assays revealed that either ONO-4817 or GM6001 significantly decreased the rate of cell proliferation compared to control (Fig. 6F) .
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To further confirm the role of MMP-2 in cell proliferation, we used the CRISPR/Cas9 system to knockout the MMP-2 gene in U2-OS cells. The mRNA, protein level and activity of MMP-2 were abolished in the CRISPR/Cas9 MMP-2 knockout cells (Fig. 7A) . Moreover, pre-rRNA levels were significantly reduced in MMP-2 deficient cells (Fig. 7B) . Most importantly, the proliferation rate of MMP-2 deficient U2-OS cells was greatly diminished (Fig. 7C) . To confirm whether the phenotype of MMP-2 deficient U2-OS cells is indeed caused by depleting MMP-2, MMP-2 was reintroduced into MMP-2 deficient cells by transient transfection. This partially rescued both pre-rRNA levels ( Fig.   7B ) and the defect in cell proliferation in MMP-2 knockout cell lines (Fig. 7C) . In summary, these data indicate that knockdown or knockout of MMP-2 or inhibition of its activity reduces rRNA transcription and inhibits the proliferation of U2-OS cells.
Discussion
In this study we defined the subnuclear localization and biological role of MMP-2.
MMP-2 had previously been reported to have a nuclear pool [17] , but its location within the nucleus and its nuclear functions have not been determined. While MMP-2 is found in a large number of small foci scattered throughout the nucleoplasm, we also observed that it enriches in a specific sub-compartment within the nucleolus, the site of rRNA transcription known as the fibrillar center. Consistent with this, we found that MMP-2 binds the rDNA promoter region and we provide evidence that MMP-2 regulates cancer cell proliferation, at least in part, through rRNA transcription. Furthermore, MMP-2 cleaves the N-terminus tail of histone H3 between the K18 and Q19 residues in nucleolar chromatin. Histone H3 clipping within the nucleolus provides a molecular mechanism by which MMP-2 could epigenetically alter rRNA transcription and thus cell proliferation.
Using unbiased degradomics approaches, several nuclear proteins have been suggested to be potential MMP-2 substrates, including histones [38] . Amongst potential targets of MMP-2, histones are of great interest. Post-translational modifications of histones through N-terminal tail clipping affects nucleosome stability by removing repressive signals to thus induce gene expression [8] . The N-terminus of histone H3, the longest N-tail of core histones, protrudes from the nucleosome at the entry point of the DNA [39] . This tail is a very important substrate for epigenetic regulation through post-translational modifications [40] . Santos-Rosa et al. reported that, in yeast, histone H3 N-tail clipping (a cleavage between Q19 and L20) was directly associated with gene promoters following the induction of transcription, and that abrogation of this tail clipping impaired gene expression [8] . The cleavage at Q19 removes 3 arginines and 4 lysines from the N-terminus (Fig. 4B) .
Apart from eliminating the potential for silencing through K9 methylation, this will reduce the net charge of the N-terminus by as much as +7, which reduces the charge more than what is possible by histone acetylation. This is expected to promote an accessible chromatin state [5, 8, 41] .
The nucleolus is divided in three components (fibrillar centre, dense fibrillar component and granular component), each with specific functions and consisting of unique proteins. At the boundary between the dense fibrillar component and fibrillar centre, rRNA transcription takes place [42] . Interestingly, MMP-2 staining within the nucleolus resembled that of nucleolar proteins involved in the regulation of rRNA transcription, including CTCF-L/BORIS [43] and nucleolin [44] . These observations prompted us to test Recently MMP-9 was found to epigenetically regulate gene expression during osteoclastogenesis in mice through histone H3 proteolysis [27] . In this study, MMP-9 was also shown to cleave histone H3 between K18 and Q19, which resulted in an upregulation of genes involved in osteoclast differentiation. Interestingly, the cleavage was stimulated by CBP/P300-mediated acetylation of K18. Our data also showed, in cells treated with a histone deacetylase inhibitor, that acetylation of nucleolar histone H3 renders it more susceptible to MMP-2 proteolysis. However, MMP-9 was shown to regulate RNA polymerase II-transcribed genes outside the nucleolus and the authors provided no evidence of a nucleolar association of MMP-9 [27] . To rule out a possible role of MMP-9 in our study, we used two different siRNAs that efficiently knocked down MMP-2 without affecting MMP-9. Thus a subset of MMPs may regulate the transcription of genes involved in cell differentiation and proliferation through a proteolytic mechanism.
We demonstrated that either inhibiting MMP-2 activity, knocking down or knocking out MMP-2 decreased both rRNA transcription and proliferation rate of human U2-OS cells. Interestingly, previous work using targeted knockdown of MMP-2 by siRNA in another human osteosarcoma cell line, SaOS2, or in murine osteoblast MC3T3 cells, resulted in decreased cellular proliferation rates [45] . Moreover, bone cells isolated from MMP-2 -/-mice exhibited slower growth rate in comparison to MMP-2 +/+ cells [45] .
Intriguingly, this deficit in cell growth was not recovered by the replacement of MMP-2 in the growth media [45] , which clearly suggests that the effect of MMP-2 on cell growth is beyond its role as an extracellular protease. The Lovett group also showed reduced proliferation of rat kidney mesangial cells upon MMP-2 knockdown [46] . These studies, however, did not provide a molecular mechanism by which MMP-2 could enhance cell proliferation. We hereby provide a mechanism which could explain these previous observations.
Collectively, we discovered that MMP-2 resides within the nucleolus where it is bound to the rDNA promoter and associates with histone H3. We propose that nucleolar MMP-2 regulates rRNA transcription and cell proliferation through proteolyzing histone 
Materials and Methods
Antibodies and reagents
The following reagents and antibodies were purchased from the indicated sources: 
Isolation of nucleoli
Nucleoli from U2-OS cells were isolated as described [47] . Briefly, cells were washed, harvested, and resuspended in nucleoli lysis buffer. Cells were disrupted and cell homogenate was centrifuged at 1,500 x g for 5 min at 4°C. The supernatant was removed and the pellet was resuspended in 500 μL solution-I. The suspension was deposited on 700 μL solution-II, and centrifuged at 2,500 x g for 5 min at 4°C. The supernatant was aspirated and the nuclei-containing pellet was resuspended in 500 μL solution-II. The isolated nuclei were sonicated on ice at 50% amplitude, using 10 s on/off cycles. Sonicated nuclei were then deposited on 700 μL solution-III and centrifuged at 3,500 x g for 10 min at 4°C to isolate nucleoli. Finally, nucleoli were lysed in 300 μL RIPA buffer (150 mM NaCl, 1.0% IGEPAL, 0.5% sodium deoxycolate, 0.1% SDS, 50 mM Tris-HCl pH 8) with 0.1% protease inhibitor cocktail (Sigma-Aldrich, P8340).
Western blotting
After electrophoresis, proteins were electrotransfered onto PVDF membranes, 
Immunofluorescence microscopy
Cells were cultured on poly-L-lysine coated coverslips, fixed with 4% paraformaldehyde for 10 min, and permeabilized with ice cold methanol for 2 min. Cells were washed with PBS and blocked with 10% goat serum for 1 h at room temperature.
Cells were incubated with primary antibodies overnight at 4°C. The solution was decanted and the cells were washed in PBS. Secondary antibodies were added and cells were incubated for 1 h. After washing with PBS, the cells were incubated with DAPI for 10 min.
The coverslips were mounted with 50% glycerol. 
Cleavage of nucleolar histone by endogenous MMP-2
Nucleolar lysates were resuspended in MMP-2 incubation buffer. To test whether endogenous MMP-2 activity could cleave nucleolar histone H3, the nucleolar suspension was incubated with or without 10 μM ARP-100 (MMP-2 preferring inhibitor) for 2 h at 4°C or 37°C.
Nucleolar histone cleavage in cells
In an experiment designed to inhibit or stimulate MMP-2 activity within intact U2-OS cells, cells were incubated with 10 μM ONO-4817 (MMP-2 preferring inhibitor), or 100 μM SIN-100 (peroxynitrite generator) for 72 h. Next, cells were washed and nucleoli were isolated as described. The nucleolar lysates were resuspended in MMP-2 incubation buffer and incubated at 37°C for 4 h. A nucleolar lysate sample from vehicle treated cells were incubated at 4°C for 4 h as a negative control. To study the effect of histone acetylation on histone H3 degradation, cells were treated with 20 μM C646 (histone acetyltranferase inhibitor), or 100 ng/mL trichostatin-A (histone deacetylase inhibitor) for 24 h prior to nucleoli isolation. Histone H3 degradation was determined using anti-H3 Nterminal or C-terminal antibodies.
Histone isolation
Histone isolation was performed using an acid extraction protocol [49] To map histone H3 cleavage site by MMP-2, isolated histones were incubated at 100:1 molar ratios with MMP-2, in presence or absence of ARP-100 (10 µM), and analyzed by immunoblotting using anti-H3 K18ac.
Nucleolar chromatin immunoprecipitation (ChIP)-qPCR
Nucleoli were prepared from fixed U2-OS cells as previously described [31] .
Briefly, cells were cross-linked by formaldehyde (0.25% in PBS for 10 min at room temperature), washed, harvested and resuspended in a total volume of 40 mL of PBS. After centrifugation, the cell pellet was resuspended in 1.0 mL of high-magnesium buffer.
Nucleoli were released by sonication on ice using a Sonifier-250 (Branson Ultrasonics).
Nucleoli were pelleted by centrifugation, and resuspended in 1.0 mL of low-magnesium buffer. Nucleoli were subjected to further sonication, pelleted and resuspended in 0. Table S1 .
MMP-2 knockdown U2-OS cells using siRNA and cell proliferation assay
The transfections mixture were prepared using MMP- were counted at 24, 48 and 72 h.
qPCR
RNA extraction was performed using RNeasy mini-kit (Qiagen). RNA concentration and purity ratios were analyzed using a NanoDrop-8000 spectrophotometer (ThermoScientific). 1 μg of total RNA was converted to cDNA using qScript-cDNA Supermix (Quantabio). qPCR was carried out on a LightCycler-480 instrument (Roche) in triplicate with SYBR Green (Roche). The sequence of the primers used were: MMP-2 forward, 5´-TGCTGAAGGACACACTAAAGAA-3´; MMP-2 reverse, 5´-CGCATGGTCTCGATGGTATT-3´; for pre-rRNA 5´ETS forward, 5´-GCCTTCTCTAGGGATCTGAGAG-3´; reverse, 5´-CCATAACGGAGGCAGAGACA-3´;
HPRT1 forward, 5´-CTGCGATGGTGGCGTTTTTG-3´; HPRT1 reverse, 5´-ACAGCGTGTCAGCAATAACC-´3.
Generation of MMP-2 knockout U2-OS cells
Guide RNAs used to target human MMP-2 (Supplementary Table S2 ) were prepared as previously described [50] using Alt-R CRISPR/Cas9 tracrRNA, ATTO-550 (IDT, Iowa) and Alt-R CRISPR/Cas9 crRNA (IDT, Iowa 
Cell viability assay
Cell viability was measured using 3-(4,5-dimethylthiazole-2-yl)-2,5-diphenyltetrazolium bromide (Sigma-Aldrich), as per the manufacturer's protocol.
Gelatin zymography for MMP-2 activity
In brief, nucleoli were isolated and nucleolar lysates were prepared and mixed with non-reducing sample loading buffer (without DTT) and loaded onto 8% poly-acrylamide gels co-polymerized with 2 mg/mL gelatin. Following electrophoresis, gels were rinsed in 2.5% Triton X-100 (3×20 min) and kept in incubation buffer for 24 h at 37°C. Gels then were stained in 0.05% Coomassie blue for 2 h and destained with methanol.
Statistical analysis
Results are expressed as mean ± S.E.M. The statistical significance of differences between the mean values was analyzed by Student's t-test, or ANOVA followed by Dunnett's post-hoc test, using GraphPad Prism 6 as indicated. Differences were considered significant at p < 0.05. 
